What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Alvotech (NASDAQ: ALVO) reshuffles leadership as Anil Okay takes over Adalvo — is this a turning point for biosimilars? Discover how Alvotech’s CCO Anil Okay’s move to Adalvo’s CEO seat could reshape commercial leadership, investor sentiment, and the global biosimilar race. byPallavi MadhirajuOctober 22, 2025